Trials / Completed
CompletedNCT04773730
Quadratus Lumborum Block Type 2 Versus Posterior Transversus Abdominus Plane Block
A Comparative Study Between Quadratus Lumborum Block Type 2 and Posterior Transversus Abdominus Plane Block for Analgesia After Cesarean Delivery Under Spinal Anesthesia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
This patient population are at risk of adverse effects secondary to inadequate pain management such as inadequate maternal bonding and late ambulation. Regional analgesia is preferred due to their opioid sparing effects and reduction in related adverse effects but the analgesia from these blocks is not known which one is superior to the other in the context of cesarean section
Detailed description
The aim of this study is to compare the effect of posterior transversus abdominus plane block and quadratus lumborum type 2 for cesarean delivery. The transversus abdominus plane(TAP) block provides sensory block from T6 to L1 for lower abdominal surgeries. Quadratous lumborum type 2 block, the injection is posterior to the quadratus lumborum muscle. This method has the advantage of a more superficial point of injection with better ultrasonographic resolution. Only one RCT was done in this context by Kalpana Verma and his colleagues comparing quadratus lumborum type 2 and posterior transversus abdominus plane block. That shows marked discrepancy with time to first analgesic request from the quadratus lumborum block in other abdominal surgeries
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Posterior transversus abdominus plane block | Twenty mL of bupivacaine 0.25% will be injected in the plane between the transverses abdominus muscle and the fascia deep to the internal oblique muscle on each side |
| PROCEDURE | Quadratus lumborum block type 2 | Twenty mL of bupivacaine 0.25% will be injected on the posterior surface of quadrates lumborum muscle on each side |
Timeline
- Start date
- 2021-03-15
- Primary completion
- 2022-08-01
- Completion
- 2023-06-03
- First posted
- 2021-02-26
- Last updated
- 2023-06-06
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04773730. Inclusion in this directory is not an endorsement.